Luo Xin Pharmaceutical: Shares of shareholders holding more than 5% in total have been judicially frozen.

Luoxin Pharmaceutical announced that on August 6, it was learned that shares held by shareholders Chengdu Deyi, Deyi Health, and Desheng Health, which collectively hold more than 5% of the shares, have been judicially frozen. A total of 9,241,258 shares are frozen, accounting for 15.74% of their holdings and 0.85% of the company's total share capital. The freeze began on August 5 and is set to expire on June 15, 2029. These shareholders are not the company's largest shareholder, and this freeze will not have a significant impact on the company's governance, daily operations, or control. However, forced execution could lead to passive reductions in holdings. The company will continue to monitor and disclose updates on this matter.